Search results for " Sclerosing"

Methylene blue-aided cholangioscopy in patients with biliary strictures: feasibility and outcome analysis

2008

BACKGROUND AND STUDY AIMS: Chromoendoscopy using methylene blue is employed in the gastrointestinal tract to delineate neoplastic lesions. We tested the value of chromoendoscopy during choledochoscopy for characterization of local inflammation, neoplasias, and other alterations in patients with biliary strictures. METHODS: Patients with suspected biliary lesions were scheduled for endoscopic retrograde cholangiography with subsequent cholangioscopy. After initial inspection of the bile duct, 15 ml methylene blue (0.1 %) was administered via the working channel of the cholangioscope. Newly appearing circumscribed or unstained lesions were judged according to their macroscopic type and staini…

1124 FERTILITY AND PREGNANCY IN PRIMARY SCLEROSING CHOLANGITIS

2010

Autoimmunhepatitis und Overlap-Syndrom: Therapie

2002

Die autoimmune Hepatitis (AIH), die primär biliäre Zirrhose (PBC) und die primär sklerosierende Cholangitis (PSC) werden zum Formenkreis der autoimmunen Lebererkrankungen gezählt. Bei diesen Lebererkrankungen spielen Immunreaktionen gegen wirtseigene Antigene eine herausragende pathogenetische Rolle. Lediglich für die AIH ist die autoimmune Ätiologie hinreichend belegt, während für die anderen beiden Erkrankungen zwar Autoimmunphänomene beschrieben wurden, jedoch die Rolle weiterer konditionierender Faktoren und infektiöser Agenzien weiter zu klären sind. Die Autoimmunhepatitis hat unbehandelt eine ungünstige Prognose und muss deshalb so früh wie möglich diagnostiziert und behandelt werden…

Aktuelle Therapie der primären sklerosierenden Cholangitis*

2008

Consensus recommendations for managing asymptomatic persistent non-virus non-alcohol related elevation of aminotransferase levels

2008

Abstract A persistent increase in non-virus non-alcohol related aminostransferase levels can have multiple causes, which differ in terms of prevalence and clinical importance. In the general population, the most frequent cause is non-alcoholic hepatic steatosis, which can evolve into steato-hepatitis and cirrhosis. The treatment for steatosis and non-alcoholic steato-hepatitis consists of modifying lifestyles, whereas the effectiveness of drug treatment remains to be determined. Other much less frequent (yet not rare) causes of persistent non-virus non-alcohol related elevations in aminotransferase levels are celiac disease and hemochromatosis, whereas autoimmune hepatitis, primary biliary …